{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:48:39Z","timestamp":1783522119975,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"DOI":"10.1007\/s12031-026-02494-0","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:26:18Z","timestamp":1771662378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of Statin use with Parkinson\u2019s Disease Progression in a Prospective Cohort Study and Multi-omics Analyses"],"prefix":"10.1007","volume":"76","author":[{"given":"Li","family":"Ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangzhou","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhou","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"key":"2494_CR1","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s10787-023-01400-z","volume":"32","author":"HM Al-kuraishy","year":"2024","unstructured":"Al-kuraishy HM, Fahad EH, Al-Windy S et al (2024) The effects of cholesterol and statins on Parkinson\u2019s neuropathology: a narrative review. Inflammopharmacol 32:917\u2013925. https:\/\/doi.org\/10.1007\/s10787-023-01400-z","journal-title":"Inflammopharmacol"},{"key":"2494_CR2","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1111\/j.1471-4159.2008.05254.x","volume":"105","author":"P Bar-On","year":"2008","unstructured":"Bar-On P, Crews L, Koob AO et al (2008) Statins reduce neuronal \u03b1-synuclein aggregation in in vitro models of Parkinson\u2019s disease. J Neurochem 105:1656\u20131667. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05254.x","journal-title":"J Neurochem"},{"key":"2494_CR3","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/s41588-021-00892-1","volume":"53","author":"AR Barton","year":"2021","unstructured":"Barton AR, Sherman MA, Mukamel RE, Loh P-R (2021) Whole-exome imputation within UK biobank powers rare coding variant association and fine-mapping analyses. Nat Genet 53:1260\u20131269. https:\/\/doi.org\/10.1038\/s41588-021-00892-1","journal-title":"Nat Genet"},{"key":"2494_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/0036933017727432","volume":"62","author":"KK Cheng","year":"2017","unstructured":"Cheng KK, Swallow DM, Grosset KA, Grosset DG (2017) Statin usage, vascular diagnosis and vascular risk factors in Parkinson\u2019s disease. Scott Med J 62:104\u2013109. https:\/\/doi.org\/10.1177\/0036933017727432","journal-title":"Scott Med J"},{"key":"2494_CR5","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.2797","volume":"45","author":"Consortium GLG","year":"2013","unstructured":"Consortium GLG (2013) Discovery and refinement of loci associated with lipid levels. Nat Genet 45:1274\u20131283. https:\/\/doi.org\/10.1038\/ng.2797","journal-title":"Nat Genet"},{"key":"2494_CR6","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/circulationaha.107.699579","volume":"117","author":"RB D\u2019Agostino","year":"2008","unstructured":"D\u2019Agostino RB, Vasan RS, Pencina MJ et al (2008) General cardiovascular risk profile for use in primary care. Circulation 117:743\u2013753. https:\/\/doi.org\/10.1161\/circulationaha.107.699579","journal-title":"Circulation"},{"key":"2494_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/science.abk0637","author":"ME Diaz-Ortiz","year":"2022","unstructured":"Diaz-Ortiz ME, Seo Y, Posavi M et al (2022) GPNMB confers risk for Parkinson\u2019s disease through interaction with \u03b1-synuclein. Science. https:\/\/doi.org\/10.1126\/science.abk0637","journal-title":"Science"},{"key":"2494_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128651","volume":"10","author":"AA Dijkstra","year":"2015","unstructured":"Dijkstra AA, Ingrassia A, de Menezes RX et al (2015) Evidence for immune response, axonal dysfunction and reduced endocytosis in the substantia nigra in early stage Parkinson\u2019s disease. PLoS One 10:e0128651\u2013e0128651. https:\/\/doi.org\/10.1371\/journal.pone.0128651","journal-title":"PLoS One"},{"key":"2494_CR9","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S (2017) Mendelian randomization. JAMA 318:1925\u20131925. https:\/\/doi.org\/10.1001\/jama.2017.17219","journal-title":"JAMA"},{"key":"2494_CR10","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00204-023-03492-6","volume":"97","author":"CA German","year":"2023","unstructured":"German CA, Liao JK (2023) Understanding the molecular mechanisms of statin pleiotropic effects. Arch Toxicol 97:1529\u20131545. https:\/\/doi.org\/10.1007\/s00204-023-03492-6","journal-title":"Arch Toxicol"},{"key":"2494_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE et al (2014) Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet 10:e1004383. https:\/\/doi.org\/10.1371\/journal.pgen.1004383","journal-title":"PLoS Genet"},{"key":"2494_CR12","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.2174\/1871527322666221128160653","volume":"22","author":"D Goswami","year":"2022","unstructured":"Goswami D, Anuradha U, Angati A et al (2022) Pharmacological and pathological relevance of S100 proteins in neurological disorders. CNS Neurol Disord Drug Targets 22:1403\u20131416. https:\/\/doi.org\/10.2174\/1871527322666221128160653","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2494_CR13","doi-asserted-by":"publisher","unstructured":"Grundy SM, Stone NJ, Bailey AL (2018) 2018\u00a0AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA\u00a0Guideline on the Management of Blood Cholesterol (2018) A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 139. https:\/\/doi.org\/10.1161\/cir.0000000000000625","DOI":"10.1161\/cir.0000000000000625"},{"key":"2494_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c2197","volume":"340","author":"J Hippisley-Cox","year":"2010","unstructured":"Hippisley-Cox J, Coupland C (2010) Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. BMJ 340:c2197\u2013c2197. https:\/\/doi.org\/10.1136\/bmj.c2197","journal-title":"BMJ"},{"key":"2494_CR15","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1002\/mds.27845","volume":"34","author":"H Iwaki","year":"2019","unstructured":"Iwaki H, Blauwendraat C, Leonard HL et al (2019) Genomewide association study of Parkinson\u2019s disease clinical biomarkers in 12 longitudinal patients\u2019 cohorts. Mov Disord 34:1839\u20131850. https:\/\/doi.org\/10.1002\/mds.27845","journal-title":"Mov Disord"},{"key":"2494_CR16","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/mds.27681","volume":"34","author":"S Jeong","year":"2019","unstructured":"Jeong S, Jang W, Shin DW (2019) Association of statin use with parkinson\u2019s disease: dose\u2013response relationship. Mov Disord 34:1014\u20131021. https:\/\/doi.org\/10.1002\/mds.27681","journal-title":"Mov Disord"},{"key":"2494_CR17","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1093\/brain\/awab292","volume":"144","author":"SH Jeong","year":"2021","unstructured":"Jeong SH, Lee HS, Chung SJ et al (2021) Effects of statins on dopamine loss and prognosis in Parkinson\u2019s disease. Brain 144:3191\u20133200. https:\/\/doi.org\/10.1093\/brain\/awab292","journal-title":"Brain"},{"key":"2494_CR18","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3233\/jpd-212819","volume":"12","author":"MM Lewis","year":"2022","unstructured":"Lewis MM, Albertson RM, Du G et al (2022) Parkinson\u2019s disease progression and statins: hydrophobicity matters. J Parkinsons Dis 12:821\u2013830. https:\/\/doi.org\/10.3233\/jpd-212819","journal-title":"J Parkinsons Dis"},{"key":"2494_CR19","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/mds.27006","volume":"32","author":"G Liu","year":"2017","unstructured":"Liu G, Sterling NW, Kong L et al (2017) Statins may facilitate Parkinson\u2019s disease: insight gained from a large, national claims database. Mov Disord 32:913\u2013917. https:\/\/doi.org\/10.1002\/mds.27006","journal-title":"Mov Disord"},{"key":"2494_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/7675496","volume":"2019","author":"D Lu","year":"2019","unstructured":"Lu D, Shen L, Mai H et al (2019) HMG-CoA reductase inhibitors attenuate neuronal damage by suppressing oxygen glucose Deprivation-Induced activated microglial cells. Neural Plast 2019:1\u201315. https:\/\/doi.org\/10.1155\/2019\/7675496","journal-title":"Neural Plast"},{"key":"2494_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","volume":"290","author":"F Mach","year":"2019","unstructured":"Mach F, Baigent C, Catapano AL et al (2019) 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Atherosclerosis 290:140\u2013205. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.08.014","journal-title":"Atherosclerosis"},{"key":"2494_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"K Marek","year":"2011","unstructured":"Marek K, Jennings D, Lasch S et al (2011) The Parkinson Progression Marker Initiative (PPMI). Prog Neurobiol 95:629\u2013635. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.09.005","journal-title":"Prog Neurobiol"},{"key":"2494_CR23","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/ng.3396","volume":"47","author":"M Nikpay","year":"2015","unstructured":"Nikpay M, Goel A, Won H-H et al (2015) A comprehensive 1000 Genomes\u2013based genome-wide association meta-analysis of coronary artery disease. Nat Genet 47:1121\u20131130. https:\/\/doi.org\/10.1038\/ng.3396","journal-title":"Nat Genet"},{"key":"2494_CR24","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3233\/jpd-212655","volume":"11","author":"G Palermo","year":"2021","unstructured":"Palermo G, Giannoni S, Giuntini M et al (2021) Statins in Parkinson\u2019s disease: influence on motor progression. JPD 11:1651\u20131662. https:\/\/doi.org\/10.3233\/jpd-212655","journal-title":"JPD"},{"key":"2494_CR25","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1212\/wnl.0000000000002001","volume":"85","author":"K Pigott","year":"2015","unstructured":"Pigott K, Rick J, Xie SX et al (2015) Longitudinal study of normal cognition in Parkinson disease. Neurology 85:1276\u20131282. https:\/\/doi.org\/10.1212\/wnl.0000000000002001","journal-title":"Neurology"},{"key":"2494_CR26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/1073858410385006","volume":"17","author":"A Roy","year":"2011","unstructured":"Roy A, Pahan K (2011) Prospects of statins in Parkinson disease. Neuroscientist 17:244\u2013255. https:\/\/doi.org\/10.1177\/1073858410385006","journal-title":"Neuroscientist"},{"key":"2494_CR27","doi-asserted-by":"publisher","first-page":"10414","DOI":"10.3390\/ijms241310414","volume":"24","author":"M Rubio-Osornio","year":"2023","unstructured":"Rubio-Osornio M, Le\u00f3n CTG-D, Montes S et al (2023) Repurposing Simvastatin in parkinson\u2019s disease model: protection is throughout modulation of the Neuro-Inflammatory response in the substantia Nigra. IJMS 24:10414. https:\/\/doi.org\/10.3390\/ijms241310414","journal-title":"IJMS"},{"key":"2494_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/s1474-4422(16)30328-3","volume":"16","author":"A Schrag","year":"2016","unstructured":"Schrag A, Siddiqui UF, Anastasiou Z et al (2016) Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed parkinson\u2019s disease: a cohort study. Lancet Neurol 16:66\u201375. https:\/\/doi.org\/10.1016\/s1474-4422(16)30328-3","journal-title":"Lancet Neurol"},{"key":"2494_CR29","unstructured":"Stevens K, Creanor S, Jeffery AN et al (2022) Evaluation of Simvastatin as a disease-Modifying treatment for patients with Parkinson disease A randomized clinical trial"},{"key":"2494_CR30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3109\/00207454.2015.1012758","volume":"126","author":"W Tan","year":"2015","unstructured":"Tan W, Xue-bin C, Tian Z et al (2015) Effects of simvastatin on the expression of inducible nitric oxide synthase and brain-derived neurotrophic factor in a lipopolysaccharide-induced rat model of Parkinson disease. Int J Neurosci 126:278\u2013286. https:\/\/doi.org\/10.3109\/00207454.2015.1012758","journal-title":"Int J Neurosci"},{"key":"2494_CR31","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen C-Y, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50:693\u2013698. https:\/\/doi.org\/10.1038\/s41588-018-0099-7","journal-title":"Nat Genet"},{"key":"2494_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.expneurol.2010.04.006","volume":"230","author":"Q Wang","year":"2010","unstructured":"Wang Q, Yan J, Chen X et al (2010) Statins: multiple neuroprotective mechanisms in neurodegenerative diseases. Exp Neurol 230:27\u201334. https:\/\/doi.org\/10.1016\/j.expneurol.2010.04.006","journal-title":"Exp Neurol"},{"key":"2494_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202310244","author":"Y Wang","year":"2024","unstructured":"Wang Y, Xu H, Chen S et al (2024) Oxytocin protects nigrostriatal dopamine signal via activating GABAergic circuit in the MPTP-induced Parkinson\u2019s disease model. Adv Sci. https:\/\/doi.org\/10.1002\/advs.202310244","journal-title":"Adv Sci"},{"key":"2494_CR34","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.2797","volume":"45","author":"CJ Willer","year":"2013","unstructured":"Willer CJ, Schmidt EM, Sengupta S et al (2013) Discovery and refinement of loci associated with lipid levels. Nat Genet 45:1274\u20131283. https:\/\/doi.org\/10.1038\/ng.2797","journal-title":"Nat Genet"},{"key":"2494_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-5-20","author":"B Wolozin","year":"2007","unstructured":"Wolozin B, Wang SW, Li N-C et al (2007) Simvastatin is associated with a reduced incidence of dementia and Parkinson\u2019s disease. BMC Med. https:\/\/doi.org\/10.1186\/1741-7015-5-20","journal-title":"BMC Med"},{"key":"2494_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000014852","volume":"98","author":"J Yan","year":"2019","unstructured":"Yan J, Qiao L, Tian J et al (2019) Effect of statins on Parkinson\u2019s disease. Med 98:e14852\u2013e14852. https:\/\/doi.org\/10.1097\/md.0000000000014852","journal-title":"Med"},{"key":"2494_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L et al (2019) Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-019-09234-6","journal-title":"Nat Commun"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-026-02494-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-026-02494-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-026-02494-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T01:43:16Z","timestamp":1774402996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-026-02494-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["2494"],"URL":"https:\/\/doi.org\/10.1007\/s12031-026-02494-0","relation":{},"ISSN":["1559-1166"],"issn-type":[{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study utilizes anonymized and de-identified data from public databases. All identifying information was removed in the original studies prior to public release.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The summary statistics for lipid traits were obtained from the Global Lipids Genetics Consortium (GLGC)and the UK Biobank. The ethical approval for each participating cohort within the GLGC was granted by their respective local Institutional Review Boards (IRBs). The meta-analysis was conducted in accordance with the principles of the Declaration of Helsinki. Further details can be found in the primary publication(Consortium\n                      \n                      ). Ethical approval for the UK Biobank study was granted by the North West Multi-centre Research Ethics Committee (MREC) (Approval ID: 11\/NW\/0382). All participants provided written informed consent.The clinical and genetic data for Parkinson\u2019s disease were sourced from the Parkinson\u2019s Progression Markers Initiative (PPMI)databasee (\n                      \n                      ), RRID: SCR 006431.This secondary analysis of de-identified, publicly available data was exempt from additional ethical approval by the Institutional Review Board of The First Affiliated Hospital of Chongqing Medical University.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}}],"article-number":"36"}}